Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.

Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.

AIMS: Missed diagnosis of maturity-onset diabetes of the young (MODY) has led to an interest in biomarkers that enable efficient prioritization of patients for definitive molecular testing. Apolipoprotein M (apoM) was suggested as a biomarker for hepatocyte nuclear factor 1 alpha (HNF1A)-MODY becaus...

Full description

Bibliographic Details
Main Authors:	Mughal, SA, Park, R, Nowak, N, Gloyn, A, Karpe, F, Matile, H, Malecki, M, McCarthy, M, Stoffel, M, Owen, K
Format:	Journal article
Language:	English
Published:	2013

Similar Items

No attenuation of CRP response to acute inflammation is seen in HNF1A-MODY
by: Owen, K, et al.
Published: (2013)

Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetes.
by: McDonald, T, et al.
Published: (2012)

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
by: McDonald, T, et al.
Published: (2011)

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
by: McDonald, T, et al.
Published: (2011)

Altered cortisol metabolism in individuals with HNF1A-MODY
by: Juszczak, A, et al.
Published: (2020)

HNF1A-MODY is associated with an intact CRP response during human endotoxaemia
by: Mughal, SA, et al.
Published: (2014)

Cystatin C is not a good candidate biomarker for HNF1A-MODY.
by: Nowak, N, et al.
Published: (2013)

Cystatin C is not a good candidate biomarker for HNF1A-MODY
by: Nowak, N, et al.
Published: (2013)

Keeping diabetes in the family: Lessons from a family with HNF-1α MODY
by: Selwood, M, et al.
Published: (2008)

Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.
by: Owen, K, et al.
Published: (2010)

Response to Comment on: McDonald et al. High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes. Diabetes Care 2011;34:1860-1862.
by: McDonald, T, et al.
Published: (2011)

Plasma fucosylated glycans and C-reactive protein as biomarkers of HNF1A-MODY in young adult–onset nonautoimmune diabetes
by: Juszczak, A, et al.
Published: (2018)

Species-specific differences in the expression of the HNF1A, HNF1B and HNF4A genes.
by: Harries, L, et al.
Published: (2009)

Identification and assessment of glycan profiles as a biomarker for maturity onset diabetes of the young (MODY) due to hepatocyte nuclear factor 1 alpha (HNF1A) mutations
by: Gloyn, A, et al.
Published: (2011)

Maturity onset diabetes of the young due to HNF1A variants in Croatia
by: Pavić, T, et al.
Published: (2018)

Hnf1alpha (MODY3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic islets and liver.
by: Servitja, J, et al.
Published: (2009)

Low frequency variants in the exons only encoding isoform A of HNF1A do not contribute to susceptibility to Type 2 diabetes
by: Jafar-Mohammadi, B, et al.
Published: (2009)

Low frequency variants in the exons only encoding isoform A of HNF1A do not contribute to susceptibility to type 2 diabetes.
by: Jafar-Mohammadi, B, et al.
Published: (2009)

Evaluation of high sensitivity C-reactive protein as a screening tool for detecting young South Asians with maturity-onset diabetes of the young due to HNF1A mutations
by: Mughal, SA, et al.
Published: (2013)

Role of low frequency variants in HNF1A exons 8-10 encoding hepatocyte nuclear factor-1 alpha isoform A to susceptibility to Type 2 diabetes
by: Jafar-Mohammadi, B, et al.
Published: (2010)

Comparison of prioritisation strategies for selecting subjects with apparent type 1 diabetes for MODY gene sequencing
by: Owen, K, et al.
Published: (2007)

The role of the HNF4alpha enhancer in type 2 diabetes.
by: Mitchell, S, et al.
Published: (2002)

Use of high sensitivity C-reactive protein and DG9-glycan index for differential diagnosis of maturity-onset diabetes of the young due to HNF1A mutations in young adults
by: Mughal, SA, et al.
Published: (2013)

Early developmental perturbations in a human stem cell model of MODY5/HNF1B pancreatic hypoplasia
by: Teo, Adrian Kee Keong, et al.
Published: (2018)

Assessment of the pathogenicity of the previously reported D526N Hepatocyte Nuclear factor-1 alpha (HNF1A) variant using a combined genetic, in silico and functional approach
by: Hassanali, N, et al.
Published: (2013)

The role of the HNF4α enhancer in type 2 diabetes variants of the HNF4α enhancer are not a common cause of susceptibility to type 2 diabetes
by: Mitchell, S, et al.
Published: (2002)

When is it MODY? Challenges in the Interpretation of Sequence Variants in MODY Genes
by: Althari, S, et al.
Published: (2016)

HNF4A haploinsufficiency in MODY1 abrogates liver and pancreas differentiation from patient-derived induced pluripotent stem cells
by: Joanita Jasmen, et al.
Published: (2019)

Mutations in HNF1A result in marked alterations of plasma glycan profile.
by: Thanabalasingham, G, et al.
Published: (2013)

A large-scale association analysis of common variation of the HNF1alpha gene with type 2 diabetes in the U.K. Caucasian population.
by: Weedon, M, et al.
Published: (2005)

Derivation and molecular characterization of pancreatic differentiated MODY1-iPSCs
by: Braverman-Gross, C, et al.
Published: (2018)

Epigenetic silencing of HNF1A associates with changes in the composition of the human plasma N-glycome.
by: Zoldoš, V, et al.
Published: (2012)

Common variants in HNF-1 alpha and risk of type 2 diabetes.
by: Holmkvist, J, et al.
Published: (2006)

Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers.
by: Gloyn, A, et al.
Published: (2012)

Leveraging on the pandemic : can Modi succeed?
by: Palit, Parama Sinha
Published: (2020)

Homozygous hypomorphic HNF1A alleles are a novel cause of young-onset diabetes and result in sulphonylurea sensitive diabetes
by: Misra, S, et al.
Published: (2020)

Large-scale type 2 diabetes association analysis of low-frequency nonsynonymous coding variants in the HNF4A gene including up to 17,600 individuals
by: Mohammadi, B, et al.
Published: (2008)

Apolipoprotein B-48.
by: Karpe, F, et al.
Published: (1996)

NO EVIDENCE FOR MUTATIONS IN THE BETA-CELL ATP-SENSITIVE POTASSIUM CHANNEL IN MODY, NIDDM OR GESTATIONAL DIABETES
by: Zhang, Y, et al.
Published: (1995)

Integration of biomarkers and clinical characteristics provides the best method for identifying patients with MODY
by: Shields, B, et al.
Published: (2012)